Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.

Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.

Item
http://www.wikidata.org/entity/Q53410584
Epigenetic modulators as therapeutic targets in prostate cancerMiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.The EMT spectrum and therapeutic opportunities.A combination of valproic acid sodium salt, CHIR99021, E-616452, tranylcypromine, and 3-Deazaneplanocin A causes stem cell-like characteristics in cancer cells.Combination of sorafenib and Valproic acid synergistically induces cell apoptosis and inhibits hepatocellular carcinoma growth via down-regulating Notch3 and pAkt.USP17 is upregulated in osteosarcoma and promotes cell proliferation, metastasis, and epithelial-mesenchymal transition through stabilizing SMAD4.Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control.Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.
P2860

Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.

Item
http://www.wikidata.org/entity/Q53410584
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Valproic acid (VPA) inhibits t ...... the dual suppression of SMAD4.
@en
type
label
Valproic acid (VPA) inhibits t ...... the dual suppression of SMAD4.
@en
prefLabel
Valproic acid (VPA) inhibits t ...... the dual suppression of SMAD4.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Valproic acid (VPA) inhibits t ...... the dual suppression of SMAD4.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698